Articles written by: Charlie Sealey

Betrium Token (BTRM) increased to $0.008389953 during a day

Betrium Token (BTRM) had a good 24 hours as the cryptocurrency jumped $0.00147477 or 21.33% trading at $0.008389953. According to Global Crypto Analysts, Betrium Token (BTRM) eyes $0.0092289483 target on the road to $0.0247669315839341. BTRM last traded at Yobit exchange. It had high of $0.008389953 and low of $0.0058179 for […]

Comparison of Mirati Therapeutics Inc. (MRTX) and Moderna Inc. (NASDAQ:MRNA)

Both Mirati Therapeutics Inc. (NASDAQ:MRTX) and Moderna Inc. (NASDAQ:MRNA) are Biotechnology companies, competing one another. We will compare their dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mirati Therapeutics Inc. 12.93M 184.99 98.42M -2.96 […]

Reviewing Immunomedics Inc. (IMMU)’s and OncoMed Pharmaceuticals Inc. (NASDAQ:OMED)’s results

We are comparing Immunomedics Inc. (NASDAQ:IMMU) and OncoMed Pharmaceuticals Inc. (NASDAQ:OMED) on their analyst recommendations, profitability, risk, institutional ownership, dividends, earnings and valuation. They both are Biotechnology companies, competing one another. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Immunomedics Inc. N/A 0.00 315.34M […]

Travel Ban Challenge to Be Heard by Supreme Court

Travel Ban Challenge to Be Heard by Supreme Court

The U.S. Supreme Court announced that it would hear the challenge of the most recent travel ban implemented by President Donald Trump. Oral arguments on the challenge will be heard starting in April. In an order of just two sentences, the court announced it would consider questions related to whether […]

Reviewing AmpliPhi Biosciences Corporation (APHB)’s and Proteon Therapeutics Inc. (NASDAQ:PRTO)’s results

We are contrasting AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) and Proteon Therapeutics Inc. (NASDAQ:PRTO) on their risk, analyst recommendations, profitability, dividends, earnings and valuation, institutional ownership. They both are Biotechnology companies, competing one another. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AmpliPhi Biosciences Corporation N/A […]

Reviewing Aduro BioTech Inc. (ADRO)’s and Midatech Pharma Plc (NASDAQ:MTP)’s results

Both Aduro BioTech Inc. (NASDAQ:ADRO) and Midatech Pharma Plc (NASDAQ:MTP) are each other?s competitor in the Biotechnology industry. Thus the contrast of their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aduro BioTech Inc. […]

Array BioPharma Inc. (ARRY) and Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCCP) Comparison side by side

As Biotechnology companies, Array BioPharma Inc. (NASDAQ:ARRY) and Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCCP) are our subject to contrast. And more specifically their dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Array BioPharma Inc. 180.09M 26.44 […]

Contrasting of BlackRock Massachusetts Tax-Exempt Trust (MHE) and Lazard Ltd (NYSE:LAZ)

This is therefore a contrasting of the risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation in BlackRock Massachusetts Tax-Exempt Trust (NYSE:MHE) and Lazard Ltd (NYSE:LAZ). The two are both Asset Management companies that compete with one another. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Verastem Inc. (VSTM)’s Financial Results Comparing With MyoKardia Inc. (NASDAQ:MYOK)

Both Verastem Inc. (NASDAQ:VSTM) and MyoKardia Inc. (NASDAQ:MYOK) compete on a level playing field in the Biotechnology industry. We will evaluate their performance with regards to risk, analyst recommendations, profitability, dividends, earnings and valuation, institutional ownership. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio […]

Credit Suisse Asset Management Income Fund Inc. (CIK) and The Carlyle Group L.P. (NASDAQ:CG) Comparing side by side

This is therefore a comparing of the risk, analyst recommendations, profitability, dividends, earnings and valuation, institutional ownership in Credit Suisse Asset Management Income Fund Inc. (NYSEAMERICAN:CIK) and The Carlyle Group L.P. (NASDAQ:CG). The two are both Asset Management companies that compete with one another. Earnings & Valuation Gross Revenue Price/Sales […]